Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 425

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia

Open access
Robinson, Clifford G., Samson, Pamela P., Moore, Kaitlin M.S., Hugo, Geoffrey D., Knutson, Nels, Mutic, Sasa, Goddu, S. Murty, Lang, Adam, Cooper, Daniel H., Faddis, Mitchell, Noheria, Amit, Smith, Timothy W., Woodard, Pamela K., Gropler, Robert J., Hallahan, Dennis E., Rudy, Yoram, Cuculich, Phillip S. · 2019 · Circulation

Abstract

Background: Case studies have suggested the efficacy of catheter-free, electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia (VT) using stereotactic body radiation therapy, although prospective data are lacking. Methods: We conducted a prospective phase I/II trial of noninvasive cardiac radioablation in adults with treatment-refractory episodes of VT or cardiomyopathy related to premature ventricular contractions (PVCs). Arrhythmogenic scar regions were targeted by combining noninvasive anatomic and electric cardiac imaging with a standard stereotactic body radiation therapy workflow followed by delivery of a single fraction of 25 Gy to the target. The primary safety end point was treatment-related serious adverse events in the first 90 days. The primary efficacy end point was any reduction in VT episodes (tracked by indwelling implantable cardioverter defibrillators) or any reduction in PVC burden (as measured by a 24-hour Holter monitor) comparing the 6 months before and after treatment (with a 6-week blanking window after treatment). Health-related quality of life was assessed using the Short Form-36 questionnaire. Results: Nineteen patients were enrolled (17 for VT, 2 for PVC cardiomyopathy). Median noninvasive ablation time was 15.3 minutes (range, 5.4–32.3). In the first 90 days, 2/19 patients (10.5%) developed a treatment-related serious adverse event. The median number of VT episodes was reduced from 119 (range, 4–292) to 3 (range, 0–31; P <0.001). Reduction was observed for both implantable cardioverter defibrillator shocks and antitachycardia pacing. VT episodes or PVC burden were reduced in 17/18 evaluable patients (94%). The frequency of VT episodes or PVC burden was reduced by 75% in 89% of patients. Overall survival was 89% at 6 months and 72% at 12 months. Use of dual antiarrhythmic medications decreased from 59% to 12% ( P =0.008). Quality of life improved in 5 of 9 Short Form-36 domains at 6 months. Conclusions: Noninvasive electrophysiology-guided cardiac radioablation is associated with markedly reduced ventricular arrhythmia burden with modest short-term risks, reduction in antiarrhythmic drug use, and improvement in quality of life. Clinical Trial Registration: URL: https://www.clinicaltrials.gov/ . Unique identifier: NCT02919618.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.118.038261

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 425

Metadata

Authors
Robinson, C. G., Samson, P. P., Moore, K. M. S., Hugo, G. D., Knutson, N., Mutic, S., Goddu, S. M., Lang, A., Cooper, D. H., Faddis, M., Noheria, A., Smith, T. W., Woodard, P. K., Gropler, R. J., Hallahan, D. E., Rudy, Y., & Cuculich, P. S.
Venue
Circulation
Published
2019-01-15
Volume
139
Issue
3
Pages
313-321
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2899649250
Cited by
425
References
20
FWCI
34.88
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia. https://app.cochat.ai/papers/10.1161/circulationaha.118.038261
The paper
Robinson, C. G., Samson, P. P., Moore, K. M. S., Hugo, G. D., Knutson, N., Mutic, S., Goddu, S. M., Lang, A., Cooper, D. H., Faddis, M., Noheria, A., Smith, T. W., Woodard, P. K., Gropler, R. J., Hallahan, D. E., Rudy, Y., & Cuculich, P. S. (2019). Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia. Circulation. https://doi.org/10.1161/circulationaha.118.038261

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.